the market will value AT1 on its expected growth, which won’t really make many take notice until the ramp up in production is fully in place , which is expected to be mid to end of 2021.
What may accelerate this and back the supply with customer orders is the FDA approval, which will mean at least 2m units will be sold to Access Bio by Sep 2021... and that is only the beginning...
but before it becomes reality/market prices it in... we need that FDA EUA early 2021.
AT1 FY21 - General Discussion + FA, page-521
-
- There are more pages in this discussion • 1,913 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
